Editorial: Molecular and nanoscale engineering of nucleic acid theranostics and vaccines

Editorial: Molecular and nanoscale engineering of nucleic acid theranostics and vaccines

Bibliographic Details
Main Authors:	Xiaohong Tan, Zilong Zhao, Ruowen Wang, Guizhi Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	synthetic nucleic acids aptamer mRNA vaccine theranostics diagnostics
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2022.1126876/full

Similar Items

Aptamers as Theranostics in Cardiovascular Diseases
by: Manish Ramchandani, et al.
Published: (2023-09-01)

Delivery of nucleic acid therapeutics for cancer immunotherapy
by: Shurong Zhou, et al.
Published: (2020-06-01)

Editorial: Nucleic acid-based aptamers in therapeutics and diagnostics
by: Anna Aviñó, et al.
Published: (2024-01-01)

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
by: Wei Duan, et al.
Published: (2013-10-01)

An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas Technology
by: Mina Roueinfar, et al.
Published: (2022-02-01)

Aptamer-based Theranostics in Oncology: Design Strategies and Limitations
by: Jyoti Trivedi, et al.
Published: (2024-04-01)

Third-Generation Vaccines: Features of Nucleic Acid Vaccines and Strategies to Improve Their Efficiency
by: Alanne Rayssa da Silva Melo, et al.
Published: (2022-12-01)

The Coming of Age of Nucleic Acid Vaccines during COVID-19
by: Halie M. Rando, et al.
Published: (2023-04-01)

Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
by: Vivek P. Chavda, et al.
Published: (2021-10-01)

Nucleic acid vaccination strategies for ovarian cancer
by: Chayanika Saha, et al.
Published: (2022-11-01)

An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
by: Rahul G. Ingle, et al.
Published: (2023-04-01)

Radiolabelled Aptamers for Theranostic Treatment of Cancer
by: Umair Khalid, et al.
Published: (2018-12-01)

Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospect
by: Tianjiao Wang, et al.
Published: (2024-01-01)

Development Trends and Suggestions of Nucleic Acid Vaccines
by: Li Aihua, et al.
Published: (2021-12-01)

Nucleic Acid Aptamers in Nanotechnology
by: Valentina V. Sinitsyna, et al.
Published: (2022-05-01)

Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
by: Jarin Taslem Mourosi, et al.
Published: (2022-05-01)

Molecular Modeling Applied to Nucleic Acid-Based Molecule Development
by: Arne Krüger, et al.
Published: (2018-08-01)

Nucleic Acids for Ultra-Sensitive Protein Detection
by: Dragana Spasic, et al.
Published: (2013-01-01)

Engineering the next generation of theranostic biomaterials with synthetic biology
by: Xiang Wang, et al.
Published: (2024-02-01)

Nanoscale MOF–Protein Composites for Theranostics
by: Xiantai Zhou, et al.
Published: (2023-08-01)

Nucleic Acid Nanotechnology for Diagnostics and Therapeutics in Acute Kidney Injury
by: Yiwen Ying, et al.
Published: (2022-03-01)

Locked and Unlocked Nucleosides in Functional Nucleic Acids
by: Birte Vester, et al.
Published: (2011-05-01)

mRNA vaccines for cancer immunotherapy
by: Yashavantha L. Vishweshwaraiah, et al.
Published: (2022-12-01)

Editorial: Novel theranostic agents for precision therapeutics
by: Shahid Karim, et al.
Published: (2024-04-01)

Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines
by: Saed Abbasi, et al.
Published: (2021-05-01)

Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII
by: Nasim Shahidi Hamedani, et al.
Published: (2021-02-01)

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
by: Q. Li, et al.
Published: (2020-08-01)

Prioritising breast cancer theranostics: A current medical longing in oncology
by: Prem N. Pandey, et al.
Published: (2021-01-01)

Novel immuno-nucleic acid cooperative detection technology for food safety
by: Xinyue Lan, et al.
Published: (2020-01-01)

Silver Nanoparticles: Synthetic Routes, In Vitro Toxicity and Theranostic Applications for Cancer Disease
by: Valeria De Matteis, et al.
Published: (2018-05-01)

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
by: Basmah N. Aldosari, et al.
Published: (2021-02-01)

Development of mucosal vaccine via respiratory tract based on mRNA-peptide-poloxamine nanoparticles
by: YANG Qihua, et al.
Published: (2023-07-01)

A generative model for constructing nucleic acid sequences binding to a protein
by: Jinho Im, et al.
Published: (2019-12-01)

Identification and Engineering of Aptamers for Theranostic Application in Human Health and Disorders
by: Debleena Basu, et al.
Published: (2021-09-01)

Functional nucleic acid-based biosensors for virus detection
by: Zijie Zhang, et al.
Published: (2023-09-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
by: Dimitri Papukashvili, et al.
Published: (2022-10-01)

Mitochondria-targeting theranostics
by: Han Chang Kang
Published: (2018-11-01)

Aptamer-Conjugated Gold Nanoparticles Targeting Human Epidermal Growth Factor Receptor 2 (HER2) for Cancer Theranostic, In Vitro Assays
by: Paola Y. Carrión-García, et al.
Published: (2023-05-01)

Generalizable anchor aptamer strategy for loading nucleic acid therapeutics on exosomes
by: Gang Han, et al.
Published: (2024-03-01)

Role of Lipid-Based and Polymer-Based Non-Viral Vectors in Nucleic Acid Delivery for Next-Generation Gene Therapy
by: Aniket Wahane, et al.
Published: (2020-06-01)